308 related articles for article (PubMed ID: 27546014)
1. The impact of field cancerization on the extent of duct carcinoma in situ (DCIS) in breast tissue after conservative excision.
Asioli S; Morandi L; Cavatorta C; Cucchi MC; Foschini MP
Eur J Surg Oncol; 2016 Dec; 42(12):1806-1813. PubMed ID: 27546014
[TBL] [Abstract][Full Text] [Related]
2. Genetic clonal mapping of in situ and invasive ductal carcinoma indicates the field cancerization phenomenon in the breast.
Foschini MP; Morandi L; Leonardi E; Flamminio F; Ishikawa Y; Masetti R; Eusebi V
Hum Pathol; 2013 Jul; 44(7):1310-9. PubMed ID: 23337025
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
van Deurzen CH
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
[TBL] [Abstract][Full Text] [Related]
4. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
5. Non-menopausal Status, High Nuclear Grade, Tumor Size >30 mm and Positive Resection Margins Are Predictors of Residual Tumor After Lumpectomy for Ductal Carcinoma In Situ of the Breast.
Joste M; Mendes V; Tixier S; Palpacuer C; Laviolle B; Leveque J; Ouldamer L
Anticancer Res; 2015 Jun; 35(6):3471-7. PubMed ID: 26026112
[TBL] [Abstract][Full Text] [Related]
6. Identifying Factors and Techniques to Decrease the Positive Margin Rate in Partial Mastectomies: Have We Missed the Mark?
Edwards SB; Leitman IM; Wengrofsky AJ; Giddins MJ; Harris E; Mills CB; Fukuhara S; Cassaro S
Breast J; 2016 May; 22(3):303-9. PubMed ID: 26854189
[TBL] [Abstract][Full Text] [Related]
7. Predictors of residual disease in repeat excisions for lumpectomies with margins less than 0.1 cm.
Rodriguez N; Diaz LK; Wiley EL
Clin Breast Cancer; 2005 Jun; 6(2):169-72. PubMed ID: 16001996
[TBL] [Abstract][Full Text] [Related]
8. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
9. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.
Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA
Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593
[TBL] [Abstract][Full Text] [Related]
10. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution.
Miligy IM; Toss MS; Khout H; Whisker L; Burrell HC; Ellis IO; Green AR; Macmillan D; Rakha EA
Breast J; 2019 Nov; 25(6):1143-1153. PubMed ID: 31318120
[TBL] [Abstract][Full Text] [Related]
12. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of extent and grade of ductal carcinoma in situ in radiologically guided core biopsy for the status of margins in lumpectomy specimens.
Mai KT; Yazdi HM; Ford JC; Matzinger FR
Eur J Surg Oncol; 2000 Nov; 26(7):646-51. PubMed ID: 11078610
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting successful breast conservation for ductal carcinoma in situ.
Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N
Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388
[TBL] [Abstract][Full Text] [Related]
15. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
[TBL] [Abstract][Full Text] [Related]
16. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
17. Residual disease after re-excision lumpectomy for close margins.
Sabel MS; Rogers K; Griffith K; Jagsi R; Kleer CG; Diehl KA; Breslin TM; Cimmino VM; Chang AE; Newman LA
J Surg Oncol; 2009 Feb; 99(2):99-103. PubMed ID: 19065638
[TBL] [Abstract][Full Text] [Related]
18. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.
Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC
J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921
[TBL] [Abstract][Full Text] [Related]
19. Does Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?
Edwards BL; Guidry CA; Larson KN; Novicoff WM; Harvey JA; Schroen AT
Ann Surg Oncol; 2016 Mar; 23(3):782-8. PubMed ID: 26471488
[TBL] [Abstract][Full Text] [Related]
20. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery.
Ward ST; Jones BG; Jewkes AJ
Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
